So should Vistagen Therapeutics (NASDAQ:VTGN) shareholders be worried about its cash burn? For the purpose of this article, we'll define cash burn as the amount of cash the company is spending each ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback